PortfoliosLab logoPortfoliosLab logo
PG vs. DFTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PG vs. DFTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Procter & Gamble Company (PG) and Definium Therapeutics, Inc (DFTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PG achieves a 5.93% return, which is significantly lower than DFTX's 84.84% return.


PG

1D
0.86%
1M
4.83%
YTD
5.93%
6M
6.28%
1Y
-3.97%
3Y*
3.69%
5Y*
4.73%
10Y*
8.96%

DFTX

1D
2.65%
1M
15.93%
YTD
84.84%
6M
97.21%
1Y
245.19%
3Y*
87.91%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

PG vs. DFTX - Yearly Performance Comparison


2026 (YTD)2025202420232022
PG
The Procter & Gamble Company
5.93%-12.26%17.25%-0.86%5.94%
DFTX
Definium Therapeutics, Inc
84.84%92.39%90.16%66.36%-78.74%

Correlation

The correlation between PG and DFTX is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.01

Correlation (3Y)
Calculated over the trailing 3-year period

0.02

Correlation (All Time)
Calculated using the full available price history since Jul 11, 2022

0.02

Fundamentals

Market Cap

PG:

$361.53B

DFTX:

$2.69B

EPS

PG:

$5.23

DFTX:

-$2.57

PB Ratio

PG:

6.70

DFTX:

9.66

Total Revenue (TTM)

PG:

$86.72B

DFTX:

$0.00

Gross Profit (TTM)

PG:

$43.64B

DFTX:

$0.00

EBITDA (TTM)

PG:

$22.63B

DFTX:

-$206.36M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PG vs. DFTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PG
PG Risk / Return Rank: 2828
Overall Rank
PG Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
PG Sortino Ratio Rank: 2525
Sortino Ratio Rank
PG Omega Ratio Rank: 2626
Omega Ratio Rank
PG Calmar Ratio Rank: 3131
Calmar Ratio Rank
PG Martin Ratio Rank: 3131
Martin Ratio Rank

DFTX
DFTX Risk / Return Rank: 9696
Overall Rank
DFTX Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
DFTX Sortino Ratio Rank: 9595
Sortino Ratio Rank
DFTX Omega Ratio Rank: 9292
Omega Ratio Rank
DFTX Calmar Ratio Rank: 9797
Calmar Ratio Rank
DFTX Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PG vs. DFTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Procter & Gamble Company (PG) and Definium Therapeutics, Inc (DFTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PGDFTXDifference
Sharpe ratioReturn per unit of total volatility

-4.20

Sortino ratioReturn per unit of downside risk

-4.24

Omega ratioGain probability vs. loss probability

0.97

1.46

-0.49

Calmar ratioReturn relative to maximum drawdown

-0.37

9.71

-10.08

Martin ratioReturn relative to average drawdown

-0.68

30.51

-31.19

PG vs. DFTX - Sharpe Ratio Comparison

The current PG Sharpe Ratio is -0.30, which is lower than the DFTX Sharpe Ratio of 3.89. The chart below compares the historical Sharpe Ratios of PG and DFTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PG vs. DFTX - Drawdown Comparison

The maximum PG drawdown since its inception was -54.25%, smaller than the maximum DFTX drawdown of -86.01%. Use the drawdown chart below to compare losses from any high point for PG and DFTX.


Loading charts...

Drawdown Indicators


PGDFTXDifference

Max Drawdown

Largest peak-to-trough decline

-54.25%

-86.01%

+31.76%

Max Drawdown (1Y)

Largest decline over 1 year

-15.52%

-24.79%

+9.27%

Max Drawdown (3Y)

Largest decline over 3 years

-21.15%

-58.38%

+37.23%

Max Drawdown (5Y)

Largest decline over 5 years

-23.77%

Max Drawdown (10Y)

Largest decline over 10 years

-23.77%

Current Drawdown

Current decline from peak

-13.29%

0.00%

-13.29%

Average Drawdown

Average peak-to-trough decline

-12.16%

-51.22%

+39.06%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.80%

7.93%

+0.87%

Volatility

PG vs. DFTX - Volatility Comparison

The current volatility for The Procter & Gamble Company (PG) is 6.99%, while Definium Therapeutics, Inc (DFTX) has a volatility of 15.21%. This indicates that PG experiences smaller price fluctuations and is considered to be less risky than DFTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PGDFTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.99%

15.21%

-8.22%

Volatility (6M)

Calculated over the trailing 6-month period

15.01%

38.79%

-23.78%

Volatility (1Y)

Calculated over the trailing 1-year period

18.78%

61.83%

-43.05%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

17.82%

83.94%

-66.12%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.05%

83.94%

-64.89%

Dividends

PG vs. DFTX - Dividend Comparison

PG's dividend yield for the trailing twelve months is around 2.85%, while DFTX has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
DFTX
Definium Therapeutics, Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PG
The Procter & Gamble Company
2.85%2.91%2.36%2.55%2.38%2.08%2.24%2.37%3.09%2.98%3.18%3.31%

Financials

PG vs. DFTX - Financials Comparison

This section allows you to compare key financial metrics between The Procter & Gamble Company and Definium Therapeutics, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B20222023202420252026
21.24B
0
(PG) Total Revenue
(DFTX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


PG and DFTX have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DFTX has higher volatility (15.21%) compared to PG (6.99%). In terms of maximum drawdown, PG dropped -54.25% vs DFTX's -86.01%.

DFTX currently has the higher Sharpe Ratio (3.89 vs -0.30), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PG and DFTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer